01.06.2011 | Review
Interpreting breast international group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer
Erschienen in: Breast Cancer Research | Ausgabe 3/2011
Einloggen, um Zugang zu erhalten